Mga Gastrointestinal Dgnstc Marrero, LA - 70072

Mga Gastrointestinal Dgnstc is categorized under Doctors in Marrero, LA and active since 1993.

Mga Gastrointestinal Dgnstc was established in 1993, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Karl Hambacher, Administrator at the company’s branch by writing to 1111 Medical Center Boulevard # 450, Marrero, Louisiana LA 70072 or by phoning (504) 349-6310. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mga Gastrointestinal Dgnstc
Contact Person: Karl Hambacher, Administrator
Address: 1111 Medical Center Boulevard # 450, Marrero, Louisiana 70072
Phone Number: (504) 349-6310
Website Address: metrogi.com
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 1993
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6214930
Share This Business:

Mga Gastrointestinal Dgnstc was started in 1993 to provide professional Doctors under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact Karl Hambacher, Administrator for inquiries that concern Mga Gastrointestinal Dgnstc by calling the company number (504) 349-6310, as your correspondence is most welcome. Additionally, the physical location of the branch of Mga Gastrointestinal Dgnstc can be found at the coordinates 29.892572,-90.095904 as well as the street address 1111 Medical Center Boulevard # 450 in Marrero, Louisiana 70072.

For its online presence, you may visit Mga Gastrointestinal Dgnstc’s website at metrogi.com and engage with its social media outlets through on Twitter and on Facebook.